Completely removing calcium deposits from your arteries is not currently possible with any diet, supplement, or medication. But slowing further calcification, stabilizing existing plaques so they’re less dangerous, and in some cases shrinking overall plaque volume are all achievable goals with strong evidence behind them. The distinction matters: the real threat isn’t calcium itself, but unstable, fatty plaques that can rupture and cause a heart attack. Calcification can actually be a sign of plaque stabilization, which is why the medical approach focuses on transforming dangerous plaques into stable ones rather than dissolving calcium.
Why Arteries Calcify in the First Place
Arterial calcification isn’t just calcium floating through your blood and sticking to artery walls. It’s an active, cell-driven process that resembles bone formation. Smooth muscle cells lining your arteries can transform into bone-like cells that secrete a protein scaffold and then load it with calcium and phosphorus minerals. These minerals crystallize into hydroxyapatite, the same compound found in your bones and teeth.
This transformation gets triggered by chronic inflammation, high blood phosphorus levels, oxidative stress, and metabolic conditions like diabetes and kidney disease. Once the process starts, elevated calcium and phosphorus in your blood accelerate the mineral buildup. Your body does have natural inhibitors that normally prevent this, but when those defenses are overwhelmed or depleted, calcification progresses.
What Your Calcium Score Actually Means
A coronary artery calcium (CAC) score, measured by a quick CT scan, quantifies how much calcification exists in the arteries supplying your heart. The scores break down into clear risk categories:
- 0: Very low risk. No detectable calcification.
- 1 to 99: Mildly increased risk. Some plaque is present.
- 100 to 299: Moderately increased risk.
- 300 or higher: Moderate to severe risk, with 10-year cardiovascular event rates as high as 13% to 26%.
Here’s the counterintuitive part: treatments that make plaques safer can actually increase your calcium score. Statins, the most widely prescribed cholesterol-lowering drugs, transform soft, rupture-prone plaques into dense, calcified ones. Your score goes up, but your risk goes down. This is why a rising CAC score during treatment doesn’t necessarily mean things are getting worse.
How Statins Reshape Plaque
Statins don’t dissolve arterial calcium. What they do is reduce total plaque volume while shifting plaque composition from dangerous to stable. Research using advanced imaging shows that without statin therapy, all types of plaque (both soft and calcified) tend to grow over time. With statin therapy, the soft, fatty components that are most likely to rupture shrink significantly, while high-density calcium increases. Think of it as trading a crumbly, unstable wall for a solid one.
Newer cholesterol-lowering treatments called PCSK9 inhibitors can push plaque regression even further when added to statins, reducing total plaque volume and the size of the dangerous fatty core inside plaques. The combination shrinks the overall disease burden in your arteries, even if the calcium component remains or increases slightly.
Vitamin K2 and Your Body’s Natural Defense
Your body produces a protein called Matrix Gla Protein (MGP) that actively prevents calcium from depositing in soft tissues like arteries. But MGP only works when it’s activated, and that activation requires vitamin K, specifically the K2 form. Without enough vitamin K2, MGP sits idle while calcium accumulates where it shouldn’t.
Activated MGP does three things: it blocks calcium crystal growth in artery walls, it prevents smooth muscle cells from transforming into bone-like cells, and it interferes with signaling pathways that promote calcification. Clinical trials have tested K2 (as menaquinone-7) at doses ranging from 90 to 360 micrograms per day over periods from 4 weeks to 3 years. While results are promising enough that trials continue, K2 is better understood as a calcification preventer than a reversal agent. Good dietary sources include fermented foods like natto, hard cheeses, and egg yolks.
Magnesium: Promising Mechanism, Mixed Results
Magnesium has a compelling biological story. In lab studies, it delays the formation of dangerous mineral particles that drive calcification, and higher blood magnesium levels correlate with fewer cardiovascular events in people with kidney disease. Animal studies consistently show it prevents vascular calcification.
But when researchers tested this in a randomized clinical trial, giving magnesium supplements to kidney disease patients for 12 months, calcium scores did not improve compared to placebo, despite blood magnesium levels rising significantly. This gap between lab promise and real-world results suggests magnesium alone isn’t enough to reverse or even slow established calcification, though maintaining adequate magnesium intake through foods like leafy greens, nuts, seeds, and whole grains remains sensible for overall cardiovascular health.
Dietary Changes That Protect Your Arteries
The dietary pattern with the strongest evidence for reducing arterial stiffness is the DASH diet (Dietary Approaches to Stop Hypertension), particularly its low-sodium version. In clinical trials, limiting sodium to around 1,150 milligrams per day while following a diet rich in fruits, vegetables, whole grains, and lean protein reduced blood pressure, arterial stiffness, and oxidative stress in patients with heart failure. For context, most people consume over 3,400 milligrams of sodium daily, so this represents a substantial reduction.
One area worth paying attention to is how you get your calcium. A large observational study following a diverse elderly population for 10 years found that high calcium intake from food was associated with less atherosclerosis. But after accounting for total calcium intake, calcium supplements were independently associated with increased coronary calcification. The takeaway: get your calcium from dairy, leafy greens, and other whole foods rather than pills when possible.
The Exercise Paradox
Regular physical activity is one of the strongest protectors against heart disease overall, but an unexpected pattern has emerged among extreme endurance athletes. Male masters athletes (those over 50 who had been running 10+ miles per week or cycling 30+ miles per week for over a decade) showed significantly higher calcium scores than matched sedentary men when any calcification was present. Among those with detectable calcium, athletes had a median score of 86 compared to just 3 in sedentary controls.
This doesn’t mean intense exercise is bad for your heart. The calcification seen in these athletes tends to be the dense, stable type rather than the soft, vulnerable kind. It may represent the same protective transformation that statins produce. Moderate exercise remains unambiguously beneficial, and even vigorous exercise reduces overall cardiovascular mortality. The finding simply means a high calcium score in a lifelong endurance athlete should be interpreted differently than the same score in a sedentary person.
What’s on the Horizon
A drug called SNF472, an intravenous formulation of a naturally occurring compound called myo-inositol hexaphosphate, is currently in phase 3 clinical trials. Unlike existing treatments that work indirectly by lowering cholesterol or blood pressure, SNF472 directly blocks the crystallization of calcium and phosphorus, targeting the mineralization process itself. Early clinical studies have confirmed both its safety and its ability to inhibit vascular calcification, making it the first therapy designed to stop hydroxyapatite crystal growth at its source. It’s being developed primarily for dialysis patients, who face the most aggressive arterial calcification, but the mechanism could eventually have broader applications.
A Practical Approach
Given the current evidence, the most effective strategy combines several layers. Aggressive cholesterol management (through medication when indicated) remains the single most impactful intervention for transforming dangerous plaques into stable ones and reducing overall plaque burden. A low-sodium, plant-rich diet protects arteries from further damage. Getting calcium from food rather than supplements avoids the paradoxical increase in arterial calcification associated with supplemental calcium. Ensuring adequate vitamin K2 intake keeps your body’s natural calcification inhibitors active. And regular moderate exercise improves every cardiovascular risk factor, even if it won’t erase existing calcium deposits.
The honest reality is that “decalcifying” arteries in the literal sense isn’t yet possible. But making calcified plaques less dangerous, stopping new calcification, and shrinking the soft plaque that actually kills people are all well within reach.